全文获取类型
收费全文 | 1594篇 |
免费 | 93篇 |
国内免费 | 287篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 36篇 |
妇产科学 | 13篇 |
基础医学 | 235篇 |
临床医学 | 211篇 |
内科学 | 740篇 |
皮肤病学 | 8篇 |
神经病学 | 60篇 |
特种医学 | 14篇 |
外科学 | 76篇 |
综合类 | 318篇 |
预防医学 | 109篇 |
眼科学 | 5篇 |
药学 | 102篇 |
中国医学 | 33篇 |
肿瘤学 | 9篇 |
出版年
2023年 | 20篇 |
2022年 | 32篇 |
2021年 | 51篇 |
2020年 | 43篇 |
2019年 | 44篇 |
2018年 | 51篇 |
2017年 | 31篇 |
2016年 | 50篇 |
2015年 | 40篇 |
2014年 | 91篇 |
2013年 | 82篇 |
2012年 | 78篇 |
2011年 | 100篇 |
2010年 | 86篇 |
2009年 | 65篇 |
2008年 | 95篇 |
2007年 | 88篇 |
2006年 | 93篇 |
2005年 | 87篇 |
2004年 | 89篇 |
2003年 | 87篇 |
2002年 | 72篇 |
2001年 | 59篇 |
2000年 | 58篇 |
1999年 | 50篇 |
1998年 | 34篇 |
1997年 | 52篇 |
1996年 | 50篇 |
1995年 | 33篇 |
1994年 | 31篇 |
1993年 | 14篇 |
1992年 | 13篇 |
1991年 | 18篇 |
1990年 | 9篇 |
1989年 | 8篇 |
1988年 | 8篇 |
1987年 | 3篇 |
1986年 | 6篇 |
1985年 | 9篇 |
1984年 | 7篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1980年 | 9篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有1974条查询结果,搜索用时 31 毫秒
1.
脂蛋白肾病(Lipoprotein glomerulopathy,LPG),1989年首次由日本学者Saito报道,LPG主要累及肾脏,且以肾小球病变为主[1]。几乎所有患者均有不同程度的蛋白尿,多数表现为肾病综合征,少数表现为轻微蛋白尿和镜下血尿,部分患者伴有不同程度的贫血及高血压,血脂异常易被忽略为肾病综合征的低蛋白血症所致。载脂蛋白E(apolipoprotein E,ApoE)增高是LPG血脂改变的主要特点[2-3]。LPG为一种与脂质代谢紊乱密切相关的肾脏疾病,目前世界范围内有报道的病例不足200例,儿童报道仅10余例[2]。本病进展缓慢,临床常误诊为原发性肾病综合征[4]。因此,为增强对LPG的认识,提高诊治水平,现分析1例确诊的儿童LPG临床资料,总结LPG的临床特点、诊断、治疗及预后。 相似文献
2.
3.
应用酶标法测定58例脑梗塞患者和56例健康对照者血清脂蛋白(a)[LP(a)]含量,并同时测定了其他脂代谢指标,对其中26例脑梗塞患者还测定了血浆纤维蛋白溶解(简称纤溶)指标。结果表明脑梗塞组存在显著的脂代谢和纤溶功能紊乱。LP(a)含量增高,与所测脂代谢、纤溶指标无显著相关,是脑梗塞发病独立的危险因素。 相似文献
4.
Diabetic patients are at increased risk of cardiovascular disease, particularly when proteinuria is present. Lipoprotein(a)[Lp(a)] levels were assessed in 37 patients with insulin dependent (IDDM) and in 75 patients with non-insulin dependent (NIDDM) diabetes who showed varying degrees of proteinuria and glycaemic control. Median Lp(a) in 112 diabetic patients was significantly greater than in 116 healthy controls (113 vs 48 mg/L; p <0.01). 86 of the patients had first morning urine albumin concentration < 30 mg/L (normoalbuminuria = NA), 16 patients 30–200 mg/L (microalbuminuria = MA) and ten patients < 200 mg/L (albuminuria = ALB). There was no significant difference in median Lp(a) concentration between the three groups (NA = 108, MA = 163, ALB = 98 mg/L; p > 0.5). No significant difference in median Lp(a) concentration was found between patients with IDDM, NIDDM treated with insulin, or NIDDM treated with oral agents and/or diet (120, 98, 115 mg/L respectively; p > 0.7). When the 86 NA patients were divided on the basis of median fructosamine concentration (357 umol/L), no significant difference was found in median Lp(a) levels between those grouped below or above this median (98 mg/L vs 118 mg/L; p < 0.5). Across all diabetics studied there was no significant correlation present between Lp(a) and urinary protein or glycaemic control. These cross-sectional results suggest that median Lp(a) concentration is increased in both IDDM and NIDDM patients, but this increase is not related to the degree of proteinuria or short-term glycaemic control. 相似文献
5.
Senile plaques in Alzheimer's disease (AD) are composed principally of Aβ, a 4 kDa fragment of the amyloid precursor protein (APP). Longer forms of APP which contain a Kunitz proteinase inhibitor (KPI) domain are elevated in aged and in AD brains. Tissue factor pathway inhibitor-1 (TFPI) contains three tandem KPI domains and has been well characterized for its role as a natural anticoagulant in the extrinsic coagulation pathway. Functionally, the first two KPI domains of TFPI bind and inhibit the activity of factor Xa and VIIa respectively. In addition, TFPI and APP-KPI share a common clearance mechanism through the low density lipoprotein receptor-related protein (LRP). As part of an ongoing study of the role of KPI-containing proteins in AD, the current study examines TFPI localization in the brain. We report here that TFPI is immunohistochemically localized to microglia in both AD and non-AD individuals and is localized to some senile plaques in AD. Western blot analyses indicate that the amount of TFPI is elevated in frontal cortex samples from AD brains. We propose that TFPI may play a cell specific role in proteinase regulation in the brain. 相似文献
6.
本文综述了新型长效雌三醇衍生物-尼尔雌醇的药理作用、代谢动力学、防治绝经后骨质疏松症和血脂紊乱实验及临床研究的进展。 相似文献
7.
Effects of a brisk walk on lipoprotein lipase activity and plasma triglyceride concentrations in the fasted and postprandial states 总被引:3,自引:0,他引:3
This study aimed to determine whether changes in plasma heparin-releasable lipoprotein lipase (LPL) activity following a brisk
walk were associated with decreases in fasting and/or postprandial triglyceride (TG) concentrations. Two groups of pre-menopausal
women participated. In one group (fasting study group, n=10), TG concentrations and post-heparin plasma LPL activity were measured in the fasted state on two occasions: ~18 h after
a 2-h treadmill walk at 50% maximal oxygen uptake (exercise trial); and after a day of no exercise (control trial). The other
group (postprandial study group, n=9) undertook two oral fat tolerance tests (blood samples taken fasting and for 6 h after a high-fat meal), with plasma LPL
activity measured 6 h after meal ingestion. Pre-conditions were the same as for the fasting study group (i.e. control and
prior exercise). Prior exercise reduced fasting TG concentrations by 23 (7)% (fasting study group) [mean (SEM)] and by 18
(9)% (postprandial study group) (both P<0.05), and the postprandial TG response by 23 (6)% (postprandial study group) (P<0.01). Plasma LPL activity was not significantly increased by exercise in either the fasting or postprandial study groups.
However, exercise-induced changes in both fasting and postprandial LPL activity were significantly correlated with the respective
exercise-induced changes in fasting TG concentration and the postprandial TG response (r=−0.70 and −0.77 respectively, P<0.05 for both). These data suggest that increased LPL activity may contribute to the hypotriglyceridaemic effect of moderate
exercise, although other mechanisms are also likely to be involved.
Electronic Publication 相似文献
8.
The mechanism of hyperlipidaemia in the nephrotic syndrome has not been fully established. We propose that it results from hypoalbuminaemia due to inhibition of the reaction catalysed by lecithin cholesterol acyltransferase converting cholesterol of high density lipoproteins to cholesterol esters and to an inhibition of high density lipoprotein particle formation from very low density lipoproteins due to reduced activity of lipoprotein lipase. 相似文献
9.
Ch. Breier A. Dzien H. -J. Lisch H. Braunsteiner 《Journal of molecular medicine (Berlin, Germany)》1984,62(12):593-594
Summary Diseases associated with acidotic blood-pH, such as chronic renal disease, diabetes mellitus or chronic alcoholism, show a marked impairment of lipoprotein lipase. Therefore we influenced blood-pH in 3 healthy subjects by infusions to get alkalotic, neutral and acidotic blood-pH on three days in series. On each day blood-pH from capillary blood and post-heparin lipoprotein lipase from fasting plasma was determined. In comparison to neutral blood-pH in vivo, alkalosis did not influence lipoprotein lipase. In contrast, during artificial acidosis, lipoprotein lipase was impaired significantly (p<0.01). Therefore, it seems, that acidosis inhibits lipoprotein lipase in vivo. 相似文献
10.
Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries 总被引:8,自引:0,他引:8
Axel Niendorf Matthias Rath Katrin Wolf Susanne Peters Hartmut Arps Ulrike Beisiegel Manfred Dietel 《Virchows Archiv : an international journal of pathology》1990,417(2):105-111
Summary Lipoprotein(a), as an atherogenic particle, represents an independent risk factor for coronary heart disease. In the present
study the morphological distribution of apoprotein (a) and apoprotein B within the arterial wall is described. Apoprotein
B, a constituent of very low-density lipoprotein, low-density lipoprotein and lipoprotein(a) has previously been demonstrated
in atheromatous lesions. Lipoprotein(a) possesses an additional protein, designated apoprotein (a). Autopsy material (n=74) from the left coronary artery and from the thoracic aorta has been examined by means of immunohistochemistry and both
apoprotein (a) and apoprotein B were detected, primarily associated with the extracellular matrix and accumulating in lesions
in the arterial wall. The staining pattern for both antigens was almost always found to be congruent, suggesting that the
detection of (a)-antigen has to be attributed at least in part to the presence of lipoprotein(a). It is concluded that both
low-density lipoprotein and lipoprotein(a) have an important role in the pathogenesis of atherosclerosis. 相似文献